Capricor Therapeutics Inc (CAPR)
9.93
-0.06
(-0.60%)
USD |
NASDAQ |
Sep 27, 16:00
10.09
+0.16
(+1.61%)
After-Hours: 19:42
Capricor Therapeutics Cash from Investing (Quarterly): 14.70M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 14.70M |
March 31, 2024 | -9.502M |
December 31, 2023 | -5.863M |
September 30, 2023 | 7.721M |
June 30, 2023 | 6.461M |
March 31, 2023 | -3.212M |
December 31, 2022 | 5.142M |
September 30, 2022 | -4.177M |
June 30, 2022 | -35.41M |
March 31, 2022 | -0.6254M |
December 31, 2021 | -0.3687M |
September 30, 2021 | -0.4682M |
June 30, 2021 | -0.3225M |
March 31, 2021 | -0.0369M |
December 31, 2020 | -0.2881M |
September 30, 2020 | -0.152M |
June 30, 2020 | -0.1075M |
March 31, 2020 | 5.987M |
December 31, 2019 | -5.987M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 2.985M |
December 31, 2018 | 3.005M |
September 30, 2018 | -0.1426M |
June 30, 2018 | -0.002M |
Date | Value |
---|---|
March 31, 2018 | 1.812M |
December 31, 2017 | -2.984M |
September 30, 2017 | -1.014M |
June 30, 2017 | 4.979M |
March 31, 2017 | 4.001M |
December 31, 2016 | -10.59M |
September 30, 2016 | -0.0146M |
June 30, 2016 | -0.0316M |
March 31, 2016 | 5.449M |
December 31, 2015 | 4.993M |
September 30, 2015 | 2.415M |
June 30, 2015 | -0.0233M |
March 31, 2015 | -15.52M |
December 31, 2014 | 0.3754M |
September 30, 2014 | -0.0711M |
June 30, 2014 | -0.069M |
March 31, 2014 | -0.0943M |
December 31, 2013 | 1.276M |
September 30, 2013 | 1.102M |
June 30, 2013 | 0.9696M |
March 31, 2013 | 0.431M |
December 31, 2012 | -4.318M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.41M
Minimum
Jun 2022
14.70M
Maximum
Jun 2024
-1.326M
Average
-0.3053M
Median
Cash from Investing (Quarterly) Benchmarks
AIM ImmunoTech Inc | 0.826M |
Perspective Therapeutics Inc | -3.295M |
Protalix BioTherapeutics Inc | -0.18M |
Electromed Inc | -0.046M |
Armata Pharmaceuticals Inc | -1.366M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -12.29M |
Cash from Financing (Quarterly) | 2.067M |
Free Cash Flow | -36.05M |
Free Cash Flow Per Share (Quarterly) | -0.3885 |
Free Cash Flow to Equity (Quarterly) | -12.37M |
Free Cash Flow Yield | -12.13% |